Japan Chemical Daily

Japan's leading chemical industry newspaper

Pharmaceutical Industry Feels Deep Impact With 2016 Drug Pricing Reform

Dec. 20, 2016

Filed Under: Industry, Pharma, Regulatory Agencies Tagged With: Central Social Insurance Medical Council, generic drugs, MHLW, Nivolumab, Ono Pharmaceutical, Opdivo, pharmaceutical, pharmaceuticals

An aspect with huge impact from the 2016 drug pricing system reform has been the provision for exceptional reprising. Implemented…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

New EU Chemical Regulations Could Impact up to 43% of Chemical Sales

New EU Chemical Regulations Could Impact up to 43% of…

India Moves to Shed Dependence on China for Active Pharmaceutical Ingredients

India Moves to Shed Dependence on China for Active…

Mitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market

Mitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market

NOF to Invest Big in DDS Materials in Anticipation of Growing Nucleic Acid Drug Market

NOF to Invest Big in DDS Materials in Anticipation of…

NOF Moves to Boost Production of DDS Materials for Biopharmaceuticals

NOF Moves to Boost Production of DDS Materials for…

Toray Enables Massive Biopharma Savings With New Continuous Purification System

Toray Enables Massive Biopharma Savings With New Continuous…

« Butadiene Reaches New High on Asian Market for 2016

Fujifilm Announces Deal to Acquire Wako »